Skip to content
Search

Latest Stories

Pharmacies face ‘triple whammy’ of rising costs, warns NPA

Pharmacies may be forced to take collective action if the government does not promptly announce a new funding settlement to cover these costs, leaders warn

Pharmacies face ‘triple whammy’ of rising costs, warns NPA

Rises in National Insurance and the National Living Wage will collectively cost pharmacies across the UK £310 million

gettyimages

The National Pharmacy Association (NPA) has warned that thousands of pharmacies in England are facing £250 million of unplanned costs this April due to increases in National Insurance and the National Living Wage.

Additionally, many pharmacies will see their business rates surge by an estimated 140 per cent, further pushing up costs.


These rising costs come on top of real-terms funding cuts of 40 per cent over the past decade, which have already led to a record number of closures.

According to the NPA, rises in National Insurance and the National Living Wage will collectively cost pharmacies across the UK £310 million.

The association has voiced concern that, without urgent government intervention, many pharmacies may be forced to reduce services or even shut their doors permanently.

Unlike other businesses, pharmacies cannot simply raise prices to offset these rising costs. Furthermore, while GPs and other parts of the NHS have received commitments to cover these increases, pharmacies have yet to receive similar assurances, despite the changes coming into effect in just six weeks.

NPA chair Nick Kaye cautioned that pharmacies face a financial “cliff edge” in April, with a “triple whammy” of rising National Insurance, National Living Wage and business rates all arriving at once.

Pharmacies have shut in record numbers and those that are left are currently hanging on by their fingernails,” Kaye said.

“Without imminent funding certainty from the government we may be left with little choice but to recommend collective action to ensure pharmacies can survive for the patients who rely on them.”

In a recent NPA ballot, 99.7 per cent of participating pharmacies indicated they would be willing to take collective action, including cutting back their opening hours for patients, if their funding situation does not improve.

The government has only recently begun consultations on pharmacy funding for the current financial year—10 months later than originally planned.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less